Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors
MOTSc: Mitochondriaderived peptide with AMPK activation and insulin sensitivity effects
Therapeutic Research Protocol Dose: 1.2 2.4 mg (= 4896 clicks) Duration: 12 20 weeks Frequency: Once weekly Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose protocol used in obesity research to evaluate sustained satiety and adiposity reduction
Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids
This IL-1 associated surge in Cx43 expression was diminished by exposure of the cell line to nobiletin (Kono et al., 2022)
US$ 25.75
US$ 29.17
US$ 24.39
